What happens after December 29 — in each case.
Most campaign sites die on the day of the meeting. This one is written so it does not have to: the outcome is not one event but four, and each one has its own next move. Read it now, while nothing is decided, and you will know what you are looking at when the filings land.
Preserve your evidence. Your broker's confirmation, your consent delivery receipt, the certified-mail return receipt for a §220 demand, and the date-stamped filings. Whichever way this goes, the holder who can produce documents is the one who is taken seriously afterwards.
515,338,334 shares consent. Then what?
What should happen, on paper
- Consents are delivered to the company and the result is disclosed in a Form 8-K.
- Eight directors are removed by written consent, effective on delivery.
- Eight nominees are elected by the same consent.
- The reconstituted board acts — including on the chief executive officer.
What to watch for
- A company statement disputing the validity of consents — expected, and decided on documents.
- Resignations, or a board that refuses to recognise the consent: that is a Chancery question.
- Timing: removal by consent is immediate on valid delivery, not at the next meeting.
- The reverse split proposal may become moot if the new board withdraws it.
It does not clear by mid-January. The effort is not wasted.
What survives
- The record of who consented, and when — a documented body of holder opinion that did not exist before this campaign.
- The Delaware litigation, which runs on its own timetable and does not need 515 million shares to matter.
- The next annual meeting, where the same votes can be cast with a lower bar.
What to watch for
- Whether a consent solicitation statement was ever filed — its absence is itself a fact worth reporting.
- Whether the company changed its bylaws, charter or record date in response.
- Whether the large holders you wrote to answered, and what they said.
Proposal 1 is approved. The board can act — but not for ever.
What happens mechanically
- A certificate of amendment is filed in Delaware, at a ratio the board chooses within the authorised range.
- Nasdaq processes the split; the ticker usually trades under a temporary suffix for a period.
- Fractional shares are cashed out — that is a real loss for small holders, not a rounding detail.
- The authorisation typically expires after twelve months if unused.
What to watch for
- The actual ratio chosen against the 1-for-2 to 1-for-500 range holders were asked to approve.
- Any further dilution after the split — a split that is followed by more issuance has achieved nothing.
- Whether the compliance problem that prompted the proposal was addressed at all.
Proposal 1 is rejected. The pressure does not end there.
What happens next
- The company still has the listing problem the proposal was meant to solve.
- Expect a revised proposal, a different ratio, or a different mechanism entirely.
- The consent campaign continues regardless — the two tracks are independent.
What to watch for
- A second special meeting called on short notice. Read the notice date carefully.
- Emergency financing on terms that dilute holders more than a split would have.
- Whether the board explains what it now intends, or simply tries again.
The Delaware case, C.A. No. 2026-1478.
The litigation over Nathaniel Bradley's removal does not depend on how anyone votes or consents. It could resolve the question faster than either campaign, and it could be decided on a legal point that no stockholder vote can reach.
What the case decides. Counts I to III are the summary track: a determination under § 225(a) and § 111 of who validly holds office, covering the October 30 suspension, the November 1 removal resolutions, the November 3 vote to approve the minutes, and the November 6 appointments — plus governance and inspection rights under § 141 and the bylaws. That track is decided on the corporate record, not by a vote, and the complaint asks for trial on it within thirty days.
What the amendment of November 13 adds. Five counts, four of them brought derivatively on the company's behalf: fraud and fraudulent concealment; equitable fraud and negligent misrepresentation, pleaded in the alternative; constructive fraud; and breach of the duty of loyalty, including good faith and candor. A fifth, civil conspiracy and aiding and abetting, is pleaded against the same three men individually and, in the alternative, derivatively. They concern the NYIAX merger and the guarantee of Abri Capital's loan rather than the removal itself, and any damages on them would be paid to Datavault — not to Bradley. No demand was made on the board; the complaint pleads that demand is excused.
What the relief would do. It asks the court to declare that Bradley is Chief Executive Officer and President, that the October 30 suspension was void from the start, that the November 1 resolutions were invalid and were not ratified on November 3, and that the November 6 appointments are without legal effect. It asks for a status quo order restraining extraordinary debt restructuring, material financing agreements and convertible-note waivers without court approval or the parties' agreement, restoring Bradley's board access, barring changes to the size or composition of the board while the case is pending, and keeping him on the annual meeting slate — and, separately, for damages against Moyer, Tirman and Hardt, jointly and severally, payable to the company.
The docket
Every filing, order and hearing date is public through the Delaware courts' system. Read the orders, not the press releases about them.
The relief sought
A declaration that the removal was ineffective is a different remedy from damages, and it changes who is running the company the day it is entered.
The timetable
Expedition matters more than the merits in a case about who controls a public company next month.
This site describes the case only as far as it appears in public filings — the verified complaint of 6 November 2026 and its amendment of 13 November 2026 — and does not take a position on its merits. Allegations in any complaint are allegations until a court says otherwise.
Nasdaq: suspended, moved to OTC, no hearing disclosed.
A suspension is not a delisting, and the company's own filing says it intends to ask a Panel to review the determination. Whether it has done so is a fact that has to come from a filing, not from an expectation — so this table states what the record shows and labels the rest as unknown.
| Date | What happened | Where it comes from |
|---|---|---|
| Date13 Nov 2026 | What happenedTen consecutive business days below $0.10; suspension of trading under Listing Rule 5810(c)(3)(A)(iii). | Where it comes fromCompany 8-K |
| Date17 Nov 2026 | What happenedTrading left the Nasdaq Capital Market; the stock is quoted on OTC Markets under the same symbol. | Where it comes fromCompany 8-K |
| DateNot dated | What happenedPanel hearing requested — the company said it intended to; no filing read for this page confirms one. | Where it comes fromUnknown |
| DateNot dated | What happenedOutcome of any hearing, or a delisting notice — none disclosed. | Where it comes fromUnknown |
Form 8-K filed 13 November 2026, which names the ten-day rule and the intention to request a Panel hearing. Checked 20 November 2026; a newer filing would supersede it.
The vote closes before the meeting. Here is what gets published next.
The vote has closed. Here is where the result appears.
Votes must be received by 11:59 p.m. ET on 28 December 2026. Nothing on this site can tell you the outcome before the company does, and no one here will guess at it.
This page is kept as a record of what was at stake. The result is not reported here first — it is reported by the company, and the links below are where to read it.
The tally
Results are reported on Form 8-K under Item 5.07 — the same form the company has filed repeatedly this month. Read the numbers, not the summary of them.
The amendment
Approval gives the board authority to amend the certificate of incorporation at any ratio between 1-for-2 and 1-for-500. The ratio and the timing are the board's choice, and the filing follows the vote rather than the other way round.
The listing
The split was sought to address the bid price. A suspension already moved the stock to OTC, so watch the listing disclosures rather than assuming the vote settles them.
Split range and the board's authority: Form PRE 14A filed 19 November 2026. Listing status: Form 8-K filed 13 November 2026. Where to read the result: the company's filings ↗.
Whatever happens, the dated record on this site is the timeline of what was proposed, when, and by whom — and Verify the vote count is how you test the number that comes out of it.
Meeting mechanics, the authorised split range and the consent threshold: Datavault AI Inc., Form PRE 14A filed November 19, 2026 and the Schedule 13D/A filed November 17, 2026. Scenario timings are general descriptions of how these processes work, not predictions.